Glenmark signs full commercial-use license for Horizon’s gene-edited CHO cells Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizonâ€), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the full commercial licensing to Glenmark Pharmaceuticals, a global innovative pharmaceutical company, of its gene-edited Glutamine Synthetase (“GSâ€) […]
PISCATAWAY, N.J. — GenScript®, the world’s leading gene synthesis provider, today announced that it will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project, the first grand scale community-wide initiative being undertaken by Genome Project-write and The Center for Excellence in Engineering Biology. The project aims […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
